Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004732 · ClinicalTrials.gov registry record · NA
Carotid Revascularization Endarterectomy Versus Stenting Trial
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 2,502
- Enrollment target
NCT00004732: Completed NA study, sponsored by Rutgers, The State University of New Jersey.
NCT00004732 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 2,502 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004732, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,502 participants
- Enrollment target
Study Summary
The purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) is to compare the relatively new procedure of stent-assisted carotid angioplasty (CAS) to the traditional and accepted surgical approach of carotid endarterectomy (CEA) for the treatment of carotid artery stenosis to prevent recurrent strokes in those patients who have had a TIA (transient ischemic attack) or a mild stroke within the past 6 months (symptomatic) and in those patients who have not had any symptoms within the past 6 months (asymptomatic).
Primary Outcome
The primary aim of CREST is to assess if the efficacy of CAS differs from that of CEA in preventing stroke, myocardial infarction and death during a 30-day peri-procedural period, or ipsilateral stroke over the follow-up period in patients with symptomatic (\>=50%) or asymptomatic (\>=60%) extracranial carotid stenosis. Four-year follow-up, proportions reflecting the absolute efficacy of carotid-artery stenting (CAS) over that of carotid endarterectomy (CEA) were based on Kaplan-Meier survival e
Interventions
- PROCEDURE Carotid Endarterectomy (CEA)
- DEVICE Carotid Artery Stenting (CAS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,502 participants |
| Start Date | 2000-12 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT00004732 record still lists
NCT00004732 is an interventional study that assigns participants to a tested intervention. Its 2,502 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% higher).
The record links to 0 conditions, and to 2 interventions - of which Carotid Endarterectomy (CEA) is the first listed.
NCT00004732 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004732 about?
NCT00004732 is a clinical study titled "Carotid Revascularization Endarterectomy Versus Stenting Trial". The purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) is to compare the relatively new procedure of stent-assisted carotid angioplasty (CAS) to the traditional and accepted surgical approach of carotid endarterectomy (CEA) for the treatment of carotid artery steno...
What is the current status of trial NCT00004732?
This trial is currently completed. It is a NA study. The enrollment target is 2,502 participants. The study started on 2000-12. Estimated completion is 2016-12.
What interventions are being tested in trial NCT00004732?
The interventions under investigation include: Carotid Endarterectomy (CEA) (PROCEDURE), Carotid Artery Stenting (CAS) (DEVICE).
Who is sponsoring clinical trial NCT00004732?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00004732's enrollment target sits among peer trials
2,502 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia